$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption

$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption

NPR | 
When a promising new drug to treat obesity was approved by the Food and Drug Administration for sale in the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists